[WEBINAR] How GLP-1 drugs change the game for food and beverage, retail, travel and beyond

From aviation to government to retail, including food and beverage, restaurants, cosmetics and skincare, and of course, healthcare, there are a wide range of sectors that could be impacted by GLP-1 usage. Gyms, manufacturers of fitness trackers, wellness monitoring devices, and even tobacco and gambling may face new challenges.

The call now is for nearly all businesses to ask themselves if they need to consider the potential impact of the GLP-1 era, asking questions like:

• How will a population that eats less buy food and beverage products differently, or eat at restaurants?
• If the population is slimmer, will my products or services benefit or will I need to reposition?
• How can consumer goods companies collaborate with healthcare providers, dietitians, and other stakeholders to support patients using GLP-1s and promote healthy lifestyle choices?

Join us for our live panel discussion on November 20 to explore how GLP-1 drugs can reshape society, featuring crucial insights from these Ipsos experts:

• Jackie Ilacqua, President, Global Syndicated Healthcare, Ipsos
• Philip Ryan, Managing Partner, Ipsos Strategy3
• Alyson Heffernan, Senior Vice President, Innovation, Ipsos

This session is part of our ongoing Insights to Activate series featuring actionable insights to drive business success. Registering will also ensure you receive a direct link to the recording once published, and notification of future events or Ipsos thought leadership on this topic.